Combination of vaccine-strain measles and mumps virus synergistically kills a wide range of human hematological cancer cells: Special focus on acute myeloid leukemia

Cancer Lett. 2014 Nov 28;354(2):272-80. doi: 10.1016/j.canlet.2014.08.034. Epub 2014 Sep 1.

Abstract

Through combining vaccine-derived measles and mumps viruses (MM), we efficiently targeted a wide range of hematopoietic cancer cell lines. MM synergistically killed many cell lines including acute myeloid leukemia (AML) cell lines. Further investigation suggested that enhanced oncolytic effect of MM was due to increased apoptosis induction. In an U937 xenograft AML mouse model, MM displayed greater tumor suppression and prolonged survival. Furthermore, MM efficiently killed blasts from 16 out of 20 AML patients and elicited more efficient killing effect on 11 patients when co-administered with Ara-C. Our results demonstrate that MM is a promising therapeutic candidate for hematological malignancies.

Keywords: Acute myeloid leukemia; Measles virus; Mumps virus; Oncolytic virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Chlorocebus aethiops
  • Cytopathogenic Effect, Viral
  • Humans
  • Jurkat Cells
  • Leukemia, Myeloid, Acute / therapy*
  • Leukemia, Myeloid, Acute / virology*
  • Male
  • Measles virus / immunology
  • Measles virus / physiology*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Mumps virus / immunology
  • Mumps virus / physiology*
  • Oncolytic Virotherapy / methods*
  • U937 Cells
  • Vero Cells
  • Xenograft Model Antitumor Assays